CULVER CITY, Calif., April 4, 2011 /PRNewswire/ — Sofie
Biosciences, a developer of molecular imaging systems and agents,
announced the launch of GENISYS4, their new benchtop small animal
PET system. Introduced today at the 2011 American Association for
Cancer Research Annual Meeting, this compact, preclinical
multimodality PET system provides researchers with the ability to
non-invasively visualize and measure the biology of disease and
therapeutic response over the course of a study.
As molecular imaging becomes an essential tool for translational
research, Sofie believes it is time for PET technology to be more
widely accessible, cost-effective, and convenient for integration
into a variety of labs.
To achieve this, PET must reduce its size and complexity while
increasing usability and performance. Furthermore, the
valuable animal models at the heart of the study should have their
physiology carefully maintained over the course of the experiment.
GENISYS4 is the answer, utilizing new advances in detector
architecture to offer unmatched sensitivity, and novel Docking
Station and Imaging Chamber designs to provide safe conditions in
an intuitive workflow experience. Compared to the traditional small
animal PET systems that are three times the cost and ten times the
size, GENISYS4 doesn’t require specially trained personnel or
expensive site planning to have researchers up and running with
minimal cost and effort.
“GENISYS4 is launching an era of compact molecular imaging
systems, just as PC companies have created a new world away from
mainframes. At only 18 inches wide and 24 inches tall, GENISYS4 is
the smallest PET imaging system in the industry, yet the most
sensitive,” said Patrick Phelps, Sofie Biosciences’ President and
Chief Executive Officer. “We are very excited to be the first to